Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD

NCT02451696 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT02451696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02451696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2014
Completion date
December 28, 2017
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, focal cortical dysplasia, tuberous sclerosis complex